ProPhase Labs Inc. (Nasdaq: PRPH) (“ProPhase”) is a next-generation biotech, genomics and consumer products company. Our mission is to build a healthier world through bold innovation and actionable insight. We’re revolutionizing healthcare with industry-leading Whole Genome Sequencing solutions, groundbreaking diagnostic development, such as our potentially life-saving test for the early detection of esophageal cancer, and a world class direct-to-consumer marketing platform for cutting edge OTC dietary supplements. We develop, manufacture, and commercialize health and wellness solutions to enable people to live their best lives. We are committed to executional excellence, smart diversification, and a synergistic, omni-channel approach. ProPhase Labs’ valuable subsidiaries, their synergies, and significant growth underscore our potential for long-term value.
Company Profile
Latest Presentation
Industry Classifications
Sector:
Healthcare
Industry:
Drug Manufacturers
NAICS:
Pharmaceutical Preparation Manufacturing (325412)
SIC:
Pharmaceutical Preparations (2834)
Contact Information
Investor Relations
Investor Relations Contact:
Dave Gentry, CEO
RedChip Companies, Inc.
T: 1-800-REDCHIP (733-2447), 1-407-644-4256
PRPH@redchip.com
Retail Investor Relations Contact:
Renmark Financial Communications
John Boidman
T: (416) 644-2020 or (212) 812-7680
jboidman@renmarkfinancial.com
https://www.renmarkfinancial.com/
Company Contact
ProPhase Labs, Inc.
626 RXR Plaza, 6th Floor
Uniondale, NY 11556